Abstract

Conflicting evidence exist regarding the effect of cancer and cancer therapy on stent healing. We sought to evaluate the need for revascularization in cancer patients treated with bare metal stents (BMS) versus drug eluting stents (DES).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call